Status
Conditions
Treatments
About
BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices.
RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients?
METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response.
ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria:
Exclusion criteria
Caregivers of patients will be excluded from this study for the following reasons:
First episode of wheezing
Admitted to the hospital
Co-morbid respiratory disease:
Current cancer diagnosis
Previous cardiovascular surgery
Inflammatory bowel disease
Sickle Cell disease
Primary purpose
Allocation
Interventional model
Masking
195 participants in 2 patient groups
Loading...
Central trial contact
Heidi Vander Velden
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal